We previously showed that motor nerves are superior to sensory nerves in promoting axon regeneration after spinal root avulsion. It is, however, impractical to use motor nerves as grafts. One potential approach to enhancing axonal regeneration using sensory nerves is to deliver trophic factors to the graft. Here, we examined the regulation of receptors for brain-derived neurotrophic factor, glial cell line<derived neurotrophic factor, ciliary neurotrophic factor, and pleiotrophin after root avulsion in adult rats. We then tested their survival-promoting and neuroregenerative effects on spinal motoneurons. The results showed that receptors for brain-derived neurotrophic factor and glial cell line<derived neurotrophic factor were upregulated and that these trophic factors promoted survival and axonal regeneration of motoneurons when they were injected into the sensory nerve graft before implantation. In contrast, receptors for ciliary neurotrophic factor and pleiotrophin were downregulated after avulsion. Ciliary neurotrophic factor did not promote survival and axonal regeneration, whereas pleiotrophin promoted axonal regeneration but not survival of injured spinal motoneurons. Our results suggest that infusion of trophic factors into sensory nerve grafts promote motoneuron survival and axonal regeneration. The technique is technically easy and is, therefore, potentially clinically applicable.
INTRODUCTION
Spinal root avulsion refers to tearing off of the spinal roots from the surface of the spinal cord. It is the most severe type of injury to the brachial plexus in humans; approximately 70% of traumatic brachial plexus injuries involve avulsion of one or more spinal root(s) (1) . The injury is most often caused by motor vehicle/cycle accidents in young adults and complicated deliveries in infants (2, 3) . Patients with avulsion experience sensory and motor function loss in the affected limb or limbs. Unlike peripheral nerve (PN) injury, avulsion causes motoneuron death (4, 5) . Current treatments involve reimplantation of the avulsed roots or grafting with PN (6Y9). The Schwann cells in the implanted nerve release neurotrophic factors for motoneuron survival (10, 11) . The nerve also acts as a conduit for axonal regeneration and reconnection with peripheral targets, leading to functional recovery (12, 13) .
We recently showed that motor nerves are superior to sensory nerves for promoting motoneuron survival and axonal regeneration after root avulsion (14) ; this is partly caused by the higher expression of brain-derived neurotrophic factor (BDNF) and glial cell line<derived neurotrophic factor (GDNF) in motor nerves. It is clinically impractical to use motor nerves for grafting. Because the harvesting of sensory nerves does not cause a major loss of motor function, autologous sensory nerves are commonly used to bridge nerve defects (15) . Moreover, there are more choices available than for mixed nerves (15, 16) . Motoneurons require trophic factors for survival during embryonic development (17, 18) and after injury in adult animals (19Y21). Neurotrophic factors for motoneurons are classified into families according to their structures. They include neurotrophins, cytokines, the transforming growth factor-A superfamily, and many others (19, 22, 23) . Although the first neurotrophic factor, nerve growth factor, was discovered more than 50 years ago (24) , the list continues to grow.
Brain-derived neurotrophic factor and GDNF are well-known neurotrophic factors for motoneurons in the neurotrophin and transforming growth factor-A families, respectively. The BDNF signals through TrkB and/or lowaffinity nerve growth factor receptor p75, whereas GDNF uses GDNF family receptor->1 (GFR->1) and c-ret. They promote motoneuron survival both in vitro and in vivo (25Y28). Numerous studies have demonstrated that they also promote axonal regeneration (29, 30) . We previously showed that these 2 neurotrophic factors promote the survival of avulsed motoneurons with either single application or continuous delivery (20, 31, 32) .
Ciliary neurotrophic factor (CNTF), a cytokine that signals through a receptor complex including CNTF receptor-> (CNTFR->), glycoprotein 130 (gp130), and leukemia inhibitory factor receptor-A (LIFR-A), is expressed throughout the nervous system. The role of CNTF in promoting axon regeneration and sprouting is controversial. It has been reported that CNTF increases myelination and axon number in the silicone tube bridging a sciatic nerve defect (33) , and it is believed to be essential for sprouting after nerve transection (34, 35) . We and others found, however, that CNTF is ineffective in promoting motoneuron survival, axonal regeneration, and sprouting (20, 36, 37) .
Pleiotrophin (PTN), which was previously known as heparin-binding growth factor 8, is a newly recognized neurotrophic factor for motoneurons (38Y40). It belongs to the midkine family and transduces its signal through a putative transmembrane tyrosine kinase receptor, anaplastic lymphoma kinase (ALK) (41) . Pleiotrophin is highly upregulated in motor nerves after axotomy (11) . It promotes motoneuron survival in an organotypic culture model and enhances axonal regeneration after sciatic nerve transection (41) . Its role in avulsed motoneurons has not yet been studied.
Here, we first assessed the protein expression of the aforementioned trophic factor receptors in motoneurons after avulsion. We then determined the survival-promoting effects of topical application of these trophic factors on motoneurons and then whether they promote motoneuron survival and axonal regeneration into autologous sensory nerve grafts when trophic factors are applied to the graft before implantation. To our knowledge, this is the first report to describe the effects of PTN on motoneuron survival and axonal regeneration after root avulsion.
MATERIALS AND METHODS

Animals
All procedures carried out in the study were approved by the Committee for the Use of Live Animals in Teaching and Research at the University of Hong Kong. A total of 74 adult male Sprague-Dawley rats weighing 280 to 320 g were used.
Surgical Procedures
Animals underwent surgical procedures similar to those previously described, with minor modifications (14) . Briefly, rats were anesthetized by intraperitoneal injection of ketamine (80 mg/kg) and xylazine (8 mg/kg). Under aseptic conditions, a dorsal hemilaminectomy at the sixth cervical vertebra was performed on the right side. The seventh cervical (C7) spinal roots were identified and then avulsed with a fine hook. Both dorsal and ventral roots were avulsed to mimic the common clinical injury. The success of avulsion was confirmed by examining any remaining rootlets under a dissecting microscope. The avulsed roots together with the spinal nerve were cut and removed.
To determine receptor expression after avulsion, no further treatment was given. Muscles and skin were sutured in layers. The animals were kept for 3 days (n = 4), 7 days (n = 4), or 28 days (n = 6) postinjury. To test the survivalpromoting effect of different trophic factors after avulsion, gelfoam soaked in 3 KL of BDNF, GDNF, CNTF (all from Peprotech, Rocky Hill, NJ), or PTN (Sigma, St Louis, MO), either 500 ng or 3 Kg, was topically applied to the avulsed segment. Normal saline was used in control animals. The animals were kept for 4 weeks; there were 3 to 6 rats for each time point.
In PN-implanted groups, neurotrophic factors were injected into the graft before implantation (n = 6 in each treatment group). Autologous saphenous nerves approximately 2.5-cm long were harvested from the right hind limb. The nerves were put on parafilm, and 1 KL of BDNF (500 ng/KL), GDNF (500 ng/KL), CNTF (500 ng/KL), or PTN (500 ng/KL) was slowly injected into the nerves from both ends with 10 KL Hamilton syringes and a 30-gauge needle (outer diameter, 285 Km). The injection was done within 1 minute to prevent the nerves from drying. Short segments from both ends were cut to remove the parts that were damaged during injection. Normal saline of the same volume was used in sham-operated controls (n = 6). The nerves were marked by 10-0 suture (EthiconYJohnson & Johnson, Somerville, NJ) on the epineurium 10 mm from the proximal end to provide a landmark for later labeling procedures.
After avulsion, a myelotomy approximately 1-mm deep was performed at the lateral funiculus. The treated nerve was implanted into the myelotomy groove and further secured in position by suturing the epineurium of the proximal end with 11Y0 suture on the pia mater. The distal end of the graft was implanted into a juxtaposed skeletal muscle. In a group of animals (n = 3) with PN implantation and topical application of GDNF, gelfoam soaked in 3 Kg/3 KL of GDNF was topically applied to the avulsed site and in close proximity to the PN graft. After the surgical procedures, muscles and skin were sutured in layers. The animals were kept warm and allowed to recover from anesthesia before returning to their cages. They were allowed to survive for up to 4 weeks.
Retrograde Motoneuron Labeling of Regenerating Axons
Two days before the animals were killed, the PN graft was exposed at the 10-mm position guided by the 10Y0 suture, and 0.5 KL of 6% FluoroGold (Fluorochrome, Denver, CO) was injected into the PN graft with a 10-KL Hamilton syringe. The animal was kept for 2 days before perfusion.
Perfusion and Tissue Processing
At the end of the survival period, the animals were given a lethal dose of sodium pentobarbital and perfused intracardially with normal saline followed by perfusion with 200 to 300 mL of fixative containing 4% paraformaldehyde in 0.1 mol/L phosphate buffer (pH 7.4). The spinal cord was harvested and postfixed with fresh fixative overnight and subsequently placed in 30% phosphate-buffered sucrose. After the samples had sunk, the cords were cut into 40-Km cross sections on a microtome. The sections were collected and stored in 0.01 mol/L PBS (pH 7.4) at 4-C for later use.
Counting of Regenerating Motoneurons
Every alternate section from PN-grafted spinal cords was examined under a fluorescence microscope (Nikon). Motoneurons that had regenerated axons for approximately 10 mm in the graft took up and retrogradely transported the FluoroGold back to the cell bodies. Under the microscope, fluorescent labeling was confined to large cells in the ipsilateral ventral horn. Therefore, the number of FluoroGoldlabeled cells represented that of regenerated motoneurons. Only those motoneurons with visible nuclei were counted to avoid double counting.
Counting of Surviving Motoneurons
To assess motoneuron survival, every alternate section from all samples was counterstained with 1% neutral red (Sigma), which stains the Nissl substance. Previous prelabeling experiments have established that motoneurons are lost after avulsion and are not merely atrophic (4, 42) . This justifies the use of Nissl stain to assess motoneuron survival. Motoneurons were counted under a light microscope by a blinded observer following the method previously described (20, 43) . Briefly, motoneurons were identified based on their size, location of cell bodies in the ventral horn, and granular appearance of Nissl bodies. Motoneurons in the contralateral and ipsilateral sides of the C7 segment were counted. Only those with visible nuclei were counted.
Semithin Section Processing
To assess the integrity of the nerves after trophic factor injection, 2 PNs were fixed 15 minutes after injection. One PN was fixed together with the Hamilton syringe in place. Normal untreated PNs were used as controls (n = 2). Three GDNF-treated nerves were harvested from implanted animals. The nerves were fixed in 2% paraformaldehyde with 2.5% glutaraldehyde overnight at 4-C and then 1% osmium tetroxide for 4 hours, dehydrated in a series of graded ethanols, cleared in propylene oxide, and embedded in pure Epon. One-millimeter semithin sections were cut on an ultramicrotome (Leica, Germany), mounted on gelatin-coated glass slides, and stained with 1% toluidine blue to visualize the myelin. Photographs were taken under a light microscope (Carl Zeiss, Germany).
Immunohistochemistry
Receptor expression at 3, 7, and 28 days after avulsion was assessed by immunohistochemistry. At least 5 spinal cord sections from each sample were used for each antibody. 
Comparative Expression of Trophic Factor Receptors
The diaminobenzidine staining intensity in motoneurons after avulsion at different time points was assessed and compared by a blinded observer. The changes of staining intensity in ipsilateral motoneurons were assigned as upregulated or downregulated slightly, strongly, or no noticeable difference compared with the contralateral motoneurons at each time point.
Data Analysis
Results are expressed as mean T SD. One-way analysis of variance and the Tukey multiple comparisons test or Student t-test, where appropriate, were used to determine the statistical significance of differences among the means. A value of p G 0.05 was considered significant.
RESULTS
Trophic Factor Receptors Are Differentially Regulated After Avulsion
We first examined the expression of receptors for the neurotrophic factors under study after root avulsion ( Fig. 1 ; Table) . At 3 days after avulsion, immunostaining of most of the receptors except CNTFR, ALK, and gp130 was upregulated in motoneurons. Changes of p75 and LIFR were most marked, whereas others showed slight increases in staining intensity. Abundant cytoplasmic staining was observed in p75-positive motoneurons (Fig. 1B) , and a similar staining pattern was seen with different sources of antibodies (44Y46). The CNTFR (Fig. 1E) and ALK (Fig. 1G) showed differential expression in which most cells seemed to have downregulated expression, whereas a few showed increased immunostaining compared with the contralateral control.
At 7 days after avulsion, expression of p75 and LIFR remained high. Expression of TrkB returned to baseline level. The CNTFR and ALK were only present in a few motoneurons per section. By contrast, the expressions of GFR->1 and RET peaked at this time point.
By 28 days postinjury, most motoneurons had died. Among those remaining, expressions of GFR->1 and LIFR were still relatively higher than those in contralateral motoneurons, whereas virtually no CNTFR or ALK was detectable. The rest of the receptors returned to basal immunostaining ALK, anaplastic lymphoma kinase; BDNF, brain-derived neurotrophic factor; CNTF, ciliary neurotrophic factor; CNTFR, CNTF receptor; GDNF, glial cell line<derived neurotrophic factor; GFR->1, GDNF family receptor->1; LIFR, leukemia inhibitory factor receptor; n.c., staining intensities are similar; PTN, pleiotrophin. FIGURE 2. Percentages of surviving motoneurons compared with the unlesioned contralateral side set at 100%. Brainderived neurotrophic factor (BDNF) and glial cell line<derived neurotrophic factor (GDNF) at the indicated doses were effective in rescuing avulsed motoneurons at 4 weeks after injury. Numbers of animals in each group are in parentheses. **, p G 0.01; ***, p G 0.001 versus saline control. CNTF, ciliary neurotrophic factor; PTN, pleiotrophin.
levels. Background staining of gp130 was high, but motoneurons could be identified. We observed no clear changes in expression throughout the study period (data not shown).
BDNF and GDNF but not CNTF and PTN Promote Survival of Motoneurons
We then tested the survival-promoting effects of topical application of the 4 neurotrophic factors at the avulsion site (Fig. 2) . A single dose of 3 Kg of BDNF was sufficient to support the survival of nearly 80% of motoneurons (75% T 18% vs 41% T 4% for avulsion control, p G 0.01) at 28 days postinjury. The lower dose (500 ng) was not effective in promoting motoneuron survival (52% T 15%). Glial cell line<derived neurotrophic factor was effective in promoting survival at both doses (86% T 7% and 88% T 9% for 500 ng and 3 Kg, respectively; both p G 0.001 vs saline control). Ciliary neurotrophic factor (34% T 4% at 500 ng, 42% T 7% at 3 Kg) and PTN (45% T 4% at 500 ng, 31% T 13% at 3 Kg) did not promote survival of motoneurons at either dose.
Neurotrophic Factor Application in Nerve Grafts Promotes Axon Regeneration
Next, we investigated whether these trophic factors enhance motoneuron axonal regeneration (Fig. 3) . Single injection of 500 ng of BDNF, GDNF, or PTN into the PN before implantation markedly increased the percentage of regenerating motoneurons (56% T 13%, p G 0.01 for BDNF; 80% T 8%, p G 0.001 for GDNF; 55% T 5%, p G 0.05 for PTN treatment vs 28% T 4% for saline treatment). Glial cell lineYderived neurotrophic factor was the most potent (p G 0.001 vs BDNF and PTN). Injection of CNTF did not promote axonal regeneration in motoneurons (23% T 11%). We also assessed motoneuron survival after trophic factor treatments. Similar to our previous studies, PN implantation after avulsion promoted the survival of motoneurons (67% T 3% vs 42% T 4%, p G 0.0001, t-test, data not shown). Exogenous application of BDNF, CNTF, or PTN in the PN did not further enhance survival. Only GDNF increased motoneuron survival to 88% T 5%, which was markedly higher than that in saline controls (p G 0.01; Fig. 3 ).
Topical application of trophic factors at the avulsion site offers 2 advantages: 1) the factors are readily taken up by the remaining axons at the ventral root exit zone; and 2) the contact area of the gelfoam (the carrier) with the spinal cord is larger, thus availability should be better along the whole avulsed segment. We tested GDNF in 2 modes of application: topical and intranerve. We used a higher dose of GDNF (3 Kg) in topical application to compensate for dilution with cerebrospinal fluid. Surprisingly, more motoneurons regenerated when GDNF was given through intranerve injection than topical application (80% T 8% vs 62% T 8%, p G 0.05), whereas the survival rates were similar (87% T 5% vs 98% T 4%, p 9 0.05; Fig. 4 ).
Injection Procedure Does Not Damage Integrity of Nerve Graft
The retrograde labeling results confirmed that the injection (Hamilton syringe, 30-gauge needle) did not cause sufficient damage to the nerve to affect axon regeneration. An average of 180 motoneurons regenerated into the normal saline<injected nerve, which is consistent with our published data (14, 47) . Semithin sections revealed the gross structure of the nerve after insertion. The epineurium of PN has great elasticity, and insertion of a 30-gauge needle did not cause it to rupture (Fig. 5B) . The nerve returned to normal size with slight disruption of fiber distribution at 15 minutes after injection (Fig. 5C ). After implantation, the GDNF-treated nerve showed a normal distribution of remyelinated fibers (Figs. 5D, E) .
DISCUSSION
We found that the receptors for BDNF and GDNF appear to be upregulated in spinal motoneurons after root avulsion. We also showed that only a single application of GDNF at the nanogram level, or a higher dose of BDNF, was sufficient to promote motoneuron survival and axon regeneration into the PN graft. On the other hand, CNTF did not have any protective or regenerative effects on avulsed motoneurons. Interestingly, PTN did not promote survival but did promote axonal regeneration of motoneurons. Nevertheless, our study suggests that delivery of trophic factors to the nerve graft encourages motor axons to navigate toward and regenerate into the graft.
Hammarberg et al (48) assessed the changes of various trophic factors and their receptors by semiquantitative in situ hybridization after avulsion. We used immunohistochemistry instead to study the protein expression of these trophic factors, and our results are in general agreement with their findings. The functional significance of the regulation of these receptors for each trophic factor is discussed later.
The transient increase of TrkB in motoneurons 3 days after avulsion suggested that BDNF exerts its maximal effect when given early after injury. Indeed, coexpression of p75, which is normally absent in adult spinal motoneurons, increases the binding affinity of BDNF to its receptor complex (49) . It seems likely that a brief exposure of BDNF mediates long-term survival in motoneurons, as demonstrated in our current and prior studies (31) . Interestingly, the expression of p75 is abundant in cytoplasm rather than on the cell surface. The significance of such expression pattern is unclear and needs further study.
The GFR->1 and c-ret, receptors for GDNF, are upregulated at the mRNA (48) and protein levels after avulsion. We showed that only a single dose of 500 ng of GDNF was sufficient to promote motoneuron survival to more than 80% at 4 weeks postinjury. We expected that the actual dose available to motoneurons would be even lower because the constantly moving cerebrospinal fluid may dilute the factor. In fact, GDNF is the most potent motoneuron survival factor identified so far (28) . As shown in our study, BDNF was only effective at the higher dose (3 Kg), but not at 500 ng, in promoting motoneuron survival, further confirming the difference in vivo.
We showed that most motoneurons downregulate CNTFR after avulsion. It is slightly upregulated in the soma and axons in only a subpopulation of motoneurons. This contrasts with the dramatic upregulation of LIFR immunoreactivity in all motoneurons. We found no change in staining intensity for gp130. Our results differ from the findings of Hammarberg et al (48) in which CNTFR mRNA is upregulated at 7 days, whereas gp130 is dramatically reduced 3 days after avulsion. We do not know the reasons for the discrepancy, but it may be related to posttranslational regulation or receptor turnover. Upregulation of CNTFR in a subgroup of motoneurons does not contradict our results for motoneuron survival because about 40% of motoneurons still survived at 4 weeks after avulsion. These cells might include those that are responsive to CNTF. It has been previously demonstrated that subgroups of motoneurons respond differently to the same trophic factor, for example, hepatocyte growth factor (50). The PTN belongs to the midkine family and is implicated in various physiological and pathological events including angiogenesis, neurogenesis, and epithelial mesenchymal interactions during organogenesis (51, 52) . It emerged as a putative neurotrophic factor for motoneurons in a microarray screen for trophic factor regulation by Schwann cells after PN injury (41) ; the authors found that PTN is upregulated after sciatic nerve transection. It protects motoneurons from death in a facial nerve transection model and an organotypic spinal cord slice culture model. The authors also compared the mRNA expression level of 4 possible PTN receptors 1 week after sciatic nerve transection and identified ALK as the putative receptor in spinal motoneurons. In the present study, we found that ALK was expressed in normal motoneurons but was downregulated after injury. Interestingly, we noticed that expression and changes of ALK were strikingly similar to CNTFR but it is not known whether they interact. We also found that PTN did not promote motoneuron survival at the 2 doses tested. Thus, our findings do not support the notion that PTN is a potent survival factor for avulsed motoneurons.
In clinical settings, promoting motoneuron survival after avulsion is not the final goal because it is more important to promote motor axon regeneration into the avulsed root/ peripheral nerve graft to rebuild the neural circuitry between the spinal cord and targeted muscles. Before this surgical technique was available, partial functional recovery of the lesioned arm was aided by palliative surgeries such as nerve transfer or muscle transfer (53Y55). Despite recent advances in surgical repair, however, functional recovery of the affected limb is still considered unsatisfactory. Axon regeneration has to be achieved to a greater degree and at a faster rate.
Because motor nerves are rarely used as a nerve graft in clinical situations, we delivered trophic factors to sensory nerve grafts to compensate for the lower level of trophic factors in this type of nerve. Our results showed that 500 ng of BDNF, GDNF, and PTN promoted axonal regeneration of motoneurons after a PN graft. Ciliary neurotrophic factor was not effective in promoting axon regeneration in injured spinal motoneurons, although it promotes survival and regeneration of retinal ganglion cells after optic nerve transection (56, 57) . We have replicated the survival-promoting effect on retinal ganglion cells using the same batch of CNTF in the study and confirmed its efficacy (data not shown).
Our results indicated that injection of trophic factor into the nerve graft might be a better strategy in promoting axon regeneration than intrathecal application. More motoneurons regenerated in the animals implanted with GDNFtreated nerve than those with GDNF applied to the spinal cord surface. In fact, transduction of spinal cord cells with adenoassociated virus encoding GDNF and BDNF promotes motoneuron survival but prevents the directional growth of axons into the reimplanted ventral root (58) . This undesired side effect is termed the candy store or growth factor oasis effect, which suggests that a high concentration of neurotrophic factor(s) at a local area retains the axons and prevents them from leaving. It is likely that GDNF in the nerve exerts neurotropism, or a directional cue, on the regenerating axons, subsequently guiding them into the implanted nerve.
It is intriguing that the receptor for PTN, ALK, was downregulated but axonal regeneration of motoneurons was enhanced. One possibility is that PTN might act synergistically with other endogenous neurotrophic factor(s) released by Schwann cells. Indeed, it is not uncommon that trophic factors working in concert result in a greater effect than any 1 factor applied alone. For example, fibroblast growth factor 2 and transforming growth factor-A3 each have only low survival-promoting activity but work synergistically to promote survival of chicken spinal motoneurons in culture (59) .
It was important to ensure that infusion of trophic factors with a microsyringe did not compromise the integrity of the PN. We are convinced that the procedures do not cause irreversible damage to the nerves, as demonstrated in our results, therefore the strategies used in this study are applicable and of high potential clinical value for avulsion injuries.
